January 08, 2025 08:50 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad
Russia may send in 2027 mission to Venus to study biomarkers in atmosphere

Russia may send in 2027 mission to Venus to study biomarkers in atmosphere

Oct 03, 2020, at 10:30 pm

Moscow/Sputnik: Russia may send an urgent space mission to Venus in 2027 to study possible signs of life in the planet’s atmosphere, a spokesperson for the Russian aerospace company NPO Lavochkin said on Saturday.

Scientists find potential sign of life in Venus

Scientists find potential sign of life in Venus

Sep 15, 2020, at 11:24 pm

An international team of astronomers today announced the discovery of a rare molecule — phosphine — in the clouds of Venus.

Venus gets marketing nod from Venezuela for meropenem

Venus gets marketing nod from Venezuela for meropenem

Apr 04, 2014, at 04:25 am

Mumbai, Apr 3 (IBNS): Venus Remedies Ltd, a research-based global pharmaceutical company, has extended its footprint in Latin America with marketing authorisation for meropenem from Venezuela, a $6-billion pharmaceutical market.